Scorpion Therapeutics
Ms. Jaiswal joined Scorpion Therapeutics in December 2020 as Executive Vice President, Finance, bringing over two decades of strategic and operational finance experience to the company. In this role, she leads the accounting, financial planning, payroll, and treasury functions.
Most recently, Ms. Jaiswal was Vice President, Finance at Fortress Biotech. Prior to joining Fortress, Ms. Jaiswal was at Regeneron Pharmaceuticals from 2008 to 2018, where she held various roles of increasing responsibility, building the finance team as the organization grew from a small start-up to a global biopharmaceutical company.
Ms. Jaiswal holds a B.E. in Chemical Engineering from National Institute of Technology Karnataka, India, an M.S. from Miami University, and an M.B.A. in Finance from New York University’s Stern School of Business.
This person is not in the org chart
This person is not in any offices
Scorpion Therapeutics
1 followers
Scorpion Therapeutics was founded to expand the reach of precision medicine to more people with cancer. The company is integrating cutting-edge technologies across target discovery, medicinal chemistry, and translational medicine to deliver Precision Oncology 2.0, a pipeline of targeted small-molecule drugs that overcome the limitations of existing treatments.